Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome

Biological Psychiatry

Volumn 44, Issue 9, 1998, Pages 930-931

  Nisijima, Koichi ^a   Kusakabe, Yasuhiro ^a   Ohtuka, Kouichiro ^a   Ishiguro, Takeo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Carbamazepine; Dopaminergic cholinergic balance; Neuroleptic malignant syndrome

Indexed keywords

BROMOCRIPTINE; CARBAMAZEPINE; CREATINE KINASE; DANTROLENE; HALOPERIDOL; LEVOMEPROMAZINE; METIXENE; NEUROLEPTIC AGENT; SULTOPRIDE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM EXPOSURE; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA;

ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 0032213925     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00025-0     Document Type: Article

References (12)

1. Amore M., Zazzeri N. Neuroleptic malignant syndrome after neuroleptic discontinuation. Prog Neuropsychopharmacol Biol Psychiatry. 19:1995;1323-1334.
2. Caroff S.N., Mann S.C. Neuroleptic malignant syndrome. Med Clin North Am. 77:1993;185-202.
3. Corrigan F.M., Coulter F. Neuroleptic malignant syndrome, amitriptyline, and thioridazine. Biol Psychiatry. 23:1988;320-321.
4. Corrigan F.M., Coulter F., Mackay A.V.P. Neuroleptic malignant syndrome (NMS) on neuroleptic withdrawal. Acta Psychiatr Scand. 82:1990;268-269.
5. Dalkin T., Lee A.S. Carbamazepine and forme fruste neuroleptic malignant syndrome. Br J Psychiatry. 157:1990;437-438.
6. Levy R.H., Kerr B.M. Clinical pharmacokinetics of carbamazepine. J Clin Psychiatry. 49:1988;58-61.
7. Müller T., Becker T., Fritze J. Neuroleptic malignant syndrome after clozapine plus carbamazepine. Lancet. ii:1988;1500.
8. Neppe V.M. Carbamazepine in nonresponsive psychosis. J Clin Psychosis. 49:1988;22-28.
9. Raitasuo V., Lehtovaara R., Huttunen M.O. Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics A case report . Psychopharmacology. 116:1994;115-116.
10. Richelson E., Nelson A. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. Eur J Pharmacol. 103:1984;197-204.
11. Spivak B., Weizman A., Wolovick L., et al. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment. Acta Psychiatr Scand. 81:1990;168-169.
12. van Amelsvoort T. Neuroleptic malignant syndrome and carbamazepine? Br J Psychiatry. 164:1994;269-270.